会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 13. 发明授权
    • Process for the preparation of 5-(2-amino-pyrimidin-4-yl)-2-aryl-1H-pyrrole-3-carboxamides
    • 制备5-(2-氨基 - 嘧啶-4-基)-2-芳基-1H-吡咯-3-甲酰胺的方法
    • US08592583B2
    • 2013-11-26
    • US13505357
    • 2010-10-27
    • Matteo D'AnelloMarco Re
    • Matteo D'AnelloMarco Re
    • C07D401/00
    • C07D403/04C07D207/34
    • The invention relates to a process for the preparation of 5-(2-amino-pyrimidin-4-yl)-2-aryl-1H-pyrrole-3-carboxamides and to the useful intermediate compounds of such process. The process allows to obtain the desired products in high yields and purity. The synthesis is starting from the coupling of an acetal with a beta-ketoester; the resultant compound is acetylated and then reacted with a dialkyl acetal of N,N-dimethylformamide to give an intermediate which is cyclized to 5-(2-amino-pyrimidin-4-yl)-2-aryl-1H-pyrrole-3-carboxylic ester; the carboxylic ester is then hydrolyzed and the resultant carboxylic acid is finally condensed with an appropriate form of ammonia to give the desired carboxamide. The compounds prepared according to the process of the invention are endowed with protein kinase inhibiting activity and, more particularly, Cdc7 or Cdc7/Cdks inhibiting activity. The compounds are useful in the treatment of a variety of cancers, cell proliferative disorders and diseases associated with protein kinases.
    • 本发明涉及制备5-(2-氨基 - 嘧啶-4-基)-2-芳基-1H-吡咯-3-甲酰胺的方法和该方法的有用的中间体化合物。 该方法允许以高产率和纯度获得所需的产物。 合成起始于缩醛与β-酮酯的偶联; 将所得化合物乙酰化,然后与N,N-二甲基甲酰胺的二烷基缩醛反应,得到中间体,将其中环化为5-(2-氨基 - 嘧啶-4-基)-2-芳基-1H-吡咯-3-基) 羧酸酯; 然后将羧酸酯水解,所得羧酸最终与适当形式的氨浓缩,得到所需的甲酰胺。 根据本发明的方法制备的化合物具有蛋白激酶抑制活性,更具体地,赋予Cdc7或Cdc7 / Cdks抑制活性。 该化合物可用于治疗各种癌症,细胞增殖性疾病和与蛋白激酶相关的疾病。
    • 15. 发明申请
    • PROCESS FOR THE PREPARATION OF 5-(2-AMINO-PYRIMIDIN-4-YL)-2-ARYL-1H-PYRROLE-3-CARBOXAMIDES
    • 制备5-(2-氨基 - 嘧啶-4-基)-2-芳基-1H-吡咯-3-羧酸的方法
    • US20120220771A1
    • 2012-08-30
    • US13505357
    • 2010-10-27
    • Matteo D'AnelloMarco Re
    • Matteo D'AnelloMarco Re
    • C07D403/04C07D207/34
    • C07D403/04C07D207/34
    • The invention relates to a process for the preparation of 5-(2-amino-pyrimidin-4-yl)-2-aryl-1H-pyrrole-3-carboxamides and to the useful intermediate compounds of such process. The process allows to obtain the desired products in high yields and purity. The synthesis is starting from the coupling of an acetal with a beta-ketoester; the resultant compound is acetylated and then reacted with a dialkyl acetal of N,N-dimethylformamide to give an intermediate which is cyclized to 5-(2-amino-pyrimidin-4-yl)-2-aryl-1H-pyrrole-3-carboxylic ester; the carboxylic ester is then hydrolyzed and the resultant carboxylic acid is finally condensed with an appropriate form of ammonia to give the desired carboxamide. The compounds prepared according to the process of the invention are endowed with protein kinase inhibiting activity and, more particularly, Cdc7 or Cdc7/Cdks inhibiting activity. The compounds are useful in the treatment of a variety of cancers, cell proliferative disorders and diseases associated with protein kinases.
    • 本发明涉及制备5-(2-氨基 - 嘧啶-4-基)-2-芳基-1H-吡咯-3-甲酰胺的方法和该方法的有用的中间体化合物。 该方法允许以高产率和纯度获得所需的产物。 合成起始于缩醛与β-酮酯的偶联; 将所得化合物乙酰化,然后与N,N-二甲基甲酰胺的二烷基缩醛反应,得到中间体,将其中环化为5-(2-氨基 - 嘧啶-4-基)-2-芳基-1H-吡咯-3-基) 羧酸酯; 然后将羧酸酯水解,所得羧酸最终与适当形式的氨浓缩,得到所需的甲酰胺。 根据本发明的方法制备的化合物具有蛋白激酶抑制活性,更具体地,赋予Cdc7或Cdc7 / Cdks抑制活性。 该化合物可用于治疗各种癌症,细胞增殖性疾病和与蛋白激酶相关的疾病。
    • 18. 发明申请
    • PROCESS FOR THE PREPARATION OF 5-(2-AMINO-PYRIMIDIN-4-YL)-2-ARYL-1H-PYRROLE-3-CARBOXAMIDES
    • 制备5-(2-氨基 - 嘧啶-4-基)-2-芳基-1H-吡咯-3-羧酸的方法
    • US20110040090A1
    • 2011-02-17
    • US12989518
    • 2009-04-30
    • Matteo D'AnelloCarlo BattistiniMaria Gioia FornarettoErmes Vanotti
    • Matteo D'AnelloCarlo BattistiniMaria Gioia FornarettoErmes Vanotti
    • C07D403/04C07D207/416
    • C07D403/04
    • The present invention relates to a process for the preparation of 5-(2-amino-pyrimidin-4-yl)-2-aryl-1H-pyrrole-3-carboxamides and to the useful intermediate compounds of such process. 5-(2-Amino-pyrimidin-4-yl)-2-aryl-1H-pyrrole-3-carboxamides are described and claimed in W02007110344, which also discloses processes for their preparation. These compounds can be advantageously prepared through a process which allows to obtain the desired products in high yields and purity and with a limited number of steps. The synthesis is starting from a cyano pyrrole derivative, and is characterized from the final hydrolysis of 5-(2-amino-pyrimidin-4-yl)-2-aryl-1H-pyrrole-3-carbonitrile. The compounds prepared according to the process of the present invention are endowed with protein kinase inhibiting activity and, more particularly, Cdc7 or Cdc7/Cdks inhibiting activity. The compounds are therefore useful in the treatment of a variety of cancers, cell proliferative disorders and diseases associated with protein kinases.
    • 本发明涉及制备5-(2-氨基 - 嘧啶-4-基)-2-芳基-1H-吡咯-3-甲酰胺的方法和该方法的有用的中间体化合物。 5-(2-氨基 - 嘧啶-4-基)-2-芳基-1H-吡咯-3-甲酰胺在WO2007110344中进行了描述和要求保护,其也公开了其制备方法。 这些化合物可以有利地通过允许以高产率和纯度以及有限数量的步骤获得所需产物的方法制备。 合成起始于氰基吡咯衍生物,其特征在于5-(2-氨基 - 嘧啶-4-基)-2-芳基-1H-吡咯-3-甲腈的最终水解。 根据本发明的方法制备的化合物具有蛋白激酶抑制活性,更具体地,赋予Cdc7或Cdc7 / Cdks抑制活性。 因此,这些化合物可用于治疗多种癌症,细胞增殖性疾病和与蛋白激酶相关的疾病。